Jaguar Health, Inc. Announces Reverse Stock Split

Jaguar Health, Inc., a NASDAQ-listed company, recently declared a reverse stock split of its common stock at a 1-for-60 ratio, effective May 23, 2024. This move, approved by shareholders at a special meeting, aims to comply with Nasdaq’s listing standards. The stock will continue to be listed under the symbol "JAGX". New CUSIP for the post-split stock is 47010C805.

Lisa Conte, CEO of Jaguar, suggested that this strategic decision may make the company more appealing to institutional investors by adjusting its share price and count. The proposal for the reverse split, detailed in the definitive proxy statement filed with the SEC on March 15, 2024, received majority approval from the voting shareholders.

Upon the split’s activation on May 23, every 60 existing shares will consolidate into one, maintaining the par value. Fractional shares arising from the split will not be issued; instead, shareholders will receive a cash settlement for fractions. Equiniti Trust Company, LLC will handle the exchange, requiring no action from shareholders who keep their stock in brokerage accounts.